Comparison of Rivaroxaban and Enoxaparin to Prevent Deep Vein Thrombosis
Phase 3
Recruiting
- Conditions
- Pelvic Fracture.Multiple fractures of lumbar spine and pelvis
- Registration Number
- IRCT20190120042419N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 112
Inclusion Criteria
Patients with Pelvic Fracture
No need for surgery
Exclusion Criteria
Having kidney disease
Use of anticoagulation drugs in less than a week
Being pregnant
Being in duration of breastfeeding
Liver disease
Having a head trauma
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Deep Vein Thrombosis. Timepoint: Two times from the beginning of the study to distance two weeks. Method of measurement: Having any signs of pain in the leg.
- Secondary Outcome Measures
Name Time Method Bleeding. Timepoint: Two times from the beginning of the study to distance two weeks. Method of measurement: Any type of abnormal bleeding will be recorded in the during the study.;Cost of intervention consumption. Timepoint: Deal of Drug consumption in during treatment. Method of measurement: Mean of consumption cost.